Despite vaccine announcements, “we’re looking at 3–5 years of COVID”

When Pfizer first announced its COVID-19 vaccine candidate in mid-November, the world’s collective hopes soared. But Chris Miller, one of Australia’s leading risk and business continuity experts, happens to know a lot about both clinical trials and supply chain management. In our recent conversation with her, she recommended keeping expectations for an expedited return to…